Maylands Dental Centre Launch Free Dental Implant and Invisalign Consultations
Maylands, Australia, May 11, 2023 (GLOBE NEWSWIRE) -- Maylands Dental Centre is a Dentist Perth that has recently launched free implant and...
Day: May 11, 2023
Admire Dental Butler: Dentist In Butler Launches New Website Under New Management
Butler, Australia, May 11, 2023 (GLOBE NEWSWIRE) -- Admire Dental Butler, a dental clinic that provides a range of oral...
South Perth Dental Surgery: Dentist In South Perth Announces New Customised Dental Implant Solutions
South Perth, Australia, May 11, 2023 (GLOBE NEWSWIRE) -- Founded in 1991, South Perth Dental Surgery is an established Dentist South...
Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%
MONTREAL, May 11, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines...
Better Choice Appoints Kent Cunningham as Chief Executive Officer
NEW YORK, May 11, 2023 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet...
Sirona Biochem: Investing News Network Interview with CSO, Dr. Geraldine Deliencourt-Godefroy
An In-Depth Look at Anti-Aging Compound TFC-1326VANCOUVER, British Columbia, May 11, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM)...
Olema Oncology Announces OP-1250 Continues to Demonstrate Attractive Combinability with CDK4/6 Inhibitor Palbociclib in Phase 1b/2 Study
OP-1250 in combination with palbociclib was well-tolerated in patients with ER+/HER2- metastatic breast cancer, with no dose-limiting toxicities, and no...
Bellerophon Therapeutics Announces Last Patient Has Completed Blinded Treatment in Phase 3 REBUILD Study for INOpulse® in Fibrotic Interstitial Lung Disease
Pivotal top-line data readout expected in mid-2023WARREN, N.J., May 11, 2023 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon”...
Venus Concept Announces 1-for-15 Reverse Stock Split
TORONTO, May 11, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical...
Vir Biotechnology Announces First Patient Dosed in New Phase 2 Chronic Hepatitis B Virus Trial Evaluating Combinations of VIR-2218, VIR-3434, PEG-IFNα and an NRTI
– STRIVE is the first Phase 2 sub-protocol trial initiated under Vir’s new PREVAIL platform trial investigating the Company’s novel...
Orion Corporation: Managers’ transactions – Mikael Silvennoinen
ORION CORPORATION MANAGERS’ TRANSACTIONS 11 MAY 2023 at 15.30 EEST Orion Corporation: Managers’ transactions – Mikael Silvennoinen Orion Corporation...
Orion Corporation: Managers’ transactions – Agendum Oy
ORION CORPORATION MANAGERS’ TRANSACTIONS 11 MAY 2023 at 15.30 EEST Orion Corporation: Managers’ transactions – Agendum Oy Orion Corporation...
Premier Health’s Subsidiary Canadian Health Care Agency Signs 2-year Agreement in British Columbia
MONTRÉAL, May 11, 2023 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Corporation” or “Premier Health”), a...
Grifols Launches AlphaID™ At Home, Enabling U.S. Consumers to Self-Screen for Genetic COPD
Now available in the U.S., this free, innovative genetic health risk service lets consumers screen for their risk of alpha1-antitrypsin...
Femasys Inc. to Showcase Four Products at the American College of Obstetricians and Gynecologists Annual Clinic & Scientific Meeting
ATLANTA, May 11, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs by...
Comera Life Sciences Reports Financial Results for First Quarter 2023 and Recent Business Highlights
– Significant progress in Comera’s ongoing research collaboration with Regeneron, a leading U.S. biotechnology company – – Further development of...
Axis Research & Technologies Announces Integration of OMNIMED™ SmartOR™
Technology Platform Gives Medical Device Companies, Surgeons and Educators Data-Driven Insights to Improve Testing and Training Axis Research & Technologies,...
Aerami Therapeutics to Present Pharmacokinetic Data Supporting AER-901 (Inhaled Imatinib) for Pulmonary Hypertension at the 2023 American Thoracic Society (ATS) International Conference
DURHAM, N.C., May 11, 2023 (GLOBE NEWSWIRE) -- Aerami Therapeutics (“Aerami”), a clinical stage biopharmaceutical company dedicated to breathing life...
Scotiabank donates $1.35M to the MUHC Foundation to create a Montreal without hepatitis C
The transformative gift supports Montréal sans HépC, an ambitious community-based program to prevent and cure hepatitis C cases in Montreal...
Oncocyte Reports First Quarter 2023 Financial Results
Nearing Manufacturing Start Up of First Kitted ProductIRVINE, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision...